GL1X · GenesisL1 explorer

MolNFT v1 · #159475 · protein

CDK2 in complex with CPD14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro- 4H-PYRAZOLO[1,5-A]AZEPIN-3-yl)-N-(5-(4-methylpiperazin-1-YL)PYRIDIN- 2-YL)PYRIMIDIN-2-amine)

6OQI · Cyclin-dependent kinase 2: “CDK2 in complex with CPD14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro…”. X-ray diffraction, 1 ligand (N14), 3 pockets (best druggability 0.71). MolNFT v1 #159475 on GenesisL1: 3D structure, binding sites…

PDB
6OQI
Type
protein
Length
290 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
N14
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein29034% helix, 17% strandP24941

Ligands and binding sites

  • N14 · 5-fluoro-N-[5-(4-methylpiperazin-1-yl)pyridin-2-yl]-4-[(4S)-4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl]pyrimidin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13510.710.8340N14
2510.300.7612empty
3520.290.7512empty

Compared structures

  • 6OQI · CDK2 in complex with Cpd14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azep… · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.